Both our in vitro and in vivo experimental results highlighted the potential of FOXM1 to stimulate the occurrence and progression of HNSCC via Linc-ROR promotion and subsequent activation of the LMO4-dependent AKT/PI3K signaling pathway. The gene discussed is FOXM1; the disease is head and neck squamous cell carcinoma.